^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    HMBD-002

    i
    Other names: HMBD-002, HMBD 002, HMBD-002-V4, HMBD-002-V4C26
    Associations
    News
    Trials
    Company:
    Hummingbird Biosci, Percheron Therapeutics
    Drug class:
    VISTA antagonist
    Related drugs:
    Associations
    News
    Trials